U.S. Point Of Care Diagnostics Market Size & Outlook
The point of care diagnostics market in the United States is expected to reach a projected revenue of US$ 10,265.0 million by 2033. A compound annual growth rate of 2.9% is expected of the United States point of care diagnostics market from 2026 to 2033.
- Clinical Diagnostics
- Point of Care (PoC) Diagnostics
- Point Of Care Diagnostics Market Outlook
- Point of Care (PoC) Diagnostics
Revenue, 2025 (US$M)
$8,148.1
Estimate, 2026 (US$M)
$8,383.7
Forecast, 2033 (US$M)
$10,265.0
CAGR, 2026 - 2033
2.9%
Global Market
Related Markets
Ask Prism AI anything about the point of care diagnostics market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
U.S. point of care diagnostics market highlights
- The U.S. point of care diagnostics market generated a revenue of USD 8,148.1 million in 2025 and is expected to reach USD 10,265.0 million by 2033.
- The U.S. market is expected to grow at a CAGR of 2.9% from 2026 to 2033.
- In terms of segment, infectious disease was the largest revenue generating product in 2025.
- Fertility/Pregnancy is the most lucrative product segment registering the fastest growth during the forecast period.
Point of care diagnostics market data book summary
| Market revenue in 2025 | USD 8,148.1 million |
| Market revenue in 2033 | USD 10,265.0 million |
| Growth rate | 2.9% (CAGR from 2026 to 2033) |
| Largest segment | Infectious disease |
| Fastest growing segment | Fertility/Pregnancy |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuse (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology |
| Key market players worldwide | F. Hoffmann-La Roche Ltd., Qiagen NV, Danaher Corp, Becton Dickinson & Co, Abbott, Siemens Healthcare GmbH, Werfen, Nova Biomedical, Trividia Health, QuidelOrtho Corp, Trinity Biotech, Sekisui Diagnostics, Orasure Technologies, Spectral Medical Inc, EKF Diagnostics Holdings PLC, Anbio Biotechnology, Accubiotech Co., Alpha Laboratories |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.4% of the global point of care diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. point of care diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,575.8 million by 2033.
No credit card required*
Publish Date: Jan 09, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point Of Care Diagnostics Market Scope
Point Of Care Diagnostics Market segmentation & scope
Point Of Care Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| EKF Diagnostics Holdings PLC | View profile | 356 | 19 Stanwell Road, Penarth, Avon House, Cardiff, United Kingdom, CF64 2EZ | www.ekfdiagnostics.com |
| Nova Biomedical | View profile | 501-1000 | Waltham, Massachusetts, United States, North America | www.novabio.us |
| Werfen | View profile | 5001-10000 | Barcelona, Catalonia, Spain, Europe | www.werfen.com/ |
| Trividia Health | View profile | 501-1000 | Fort Lauderdale, Florida, United States, North America | trividiahealth.com |
| Spectral Medical Inc | View profile | 29 | 135 The West Mall, Unit 2, Finance, Toronto, ON, Canada, M9C 1C2 | www.spectraldx.com |
| Sekisui Diagnostics | View profile | 501-1000 | Lexington, Massachusetts, United States, North America | sekisuidiagnostics.com |
U.S. Point Of Care Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Point Of Care Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Infectious Disease was the largest segment with a revenue share of 40.14% in 2025.
Horizon Databook has segmented the U.S. point of care diagnostics market based on glucose testing, hb1ac testing, coagulation testing, fertility/pregnancy, infectious disease, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug of abuse (doa) testing, autoimmune diseases, urinalysis/nephrology covering the revenue growth of each sub-segment from 2021 to 2033.
- U.S. Point Of Care Diagnostics Market Product Outlook (Revenue, USD Million , 2021-2033)
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug of Abuse (DOA) Testing
- Autoimmune Diseases
- Urinalysis/Nephrology
- U.S. Point Of Care Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
Reasons to subscribe to Point Of Care Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Point Of Care Diagnostics Market Outlook databook
- Our clientele includes a mix of Point Of Care Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Point Of Care Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Point Of Care Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Point Of Care Diagnostics Market, 2021-2033 (US$M)
US Product - Point Of Care Diagnostics Market Statistics, 2025 - 2033 (US$M)
